Viewing Study NCT00062504


Ignite Creation Date: 2025-12-24 @ 8:01 PM
Ignite Modification Date: 2025-12-25 @ 5:34 PM
Study NCT ID: NCT00062504
Status: TERMINATED
Last Update Posted: 2011-05-23
First Post: 2003-06-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module